Showing results (1-10 of 521) with videos related to

Sort By:
Pageof 53
International Journal of Mycobacteriology|January 4, 2017
Host-directed therapies for multidrug resistant tuberculosisAlimuddin Zumla, Markus Maeurer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2015
Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp DebatesAlimuddin Zumla, Markus Maeurer,
Current Opinion in Pulmonary Medicine|March 19, 2016
Host-directed therapies for antimicrobial resistant respiratory tract infectionsMarkus Maeurer, Martin Rao, Alimuddin Zumla
The American Journal of Medicine|May 22, 2012
Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infectionsGiovanni Ferrara, Alimuddin Zumla, Markus Maeurer
The Journal of Infectious Diseases|March 30, 2012
Adjunct immunotherapies for tuberculosisMichael Uhlin, Jan Andersson, Alimuddin Zumla, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 5, 2018
Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosisMartin Rao, Davide Valentini, Alimuddin Zumla, et al.
BMC Medicine|June 16, 2016
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosisAlimuddin Zumla, Martin Rao, Ernest Dodoo, et al.
Frontiers in Microbiology|May 29, 2019
Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed TherapiesMartin Rao, Ernest Dodoo, Alimuddin Zumla, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 27, 2015
Host-directed therapies for tuberculous pericarditisAlimuddin Zumla, Markus Maeurer, Guido Moll, et al.
Pageof 53